---
_schema: default
id: 88687
date: 2024-12-04
title: >-
    How does increased selectin ligand expression contribute to cancer metastasis?
article_title: >-
    How does increased selectin ligand expression contribute to cancer metastasis?
date_format: MMM DD, YYYY
post_on_text: Posted on
seo:
  title: QuickTakes | Medicine
  page_description: >-
    Increased selectin ligand expression enhances cancer cell adhesion to endothelium, promotes integrin activation, and creates a supportive microenvironment for metastasis, highlighting its importance in cancer progression and as a potential therapeutic target.
  page_keywords: >-
    selectin ligands, cancer metastasis, endothelial adhesion, integrins activation, chemokine release, tumor microenvironment, circulating tumor cells, therapeutic targets, prognosis, metastatic potential
author: QuickTakes
question: >-
    How does increased selectin ligand expression contribute to cancer metastasis?
answer: >-
    Increased selectin ligand expression on cancer cells significantly contributes to cancer metastasis through several mechanisms. The degree of selectin ligand expression is well correlated with metastasis and poor prognosis in cancer patients. This correlation suggests that selectin ligands play a critical role in the initial adhesion of cancer cells to the endothelium, which is a crucial step in the metastatic process.\n\nWhen cancer cells express higher levels of selectin ligands, they can effectively bind to selectins on endothelial cells. This initial adhesion event is not merely a passive interaction; it activates integrins on the cancer cells, which further enhances their ability to adhere to the vascular endothelium and facilitates extravasation into distant tissues. The binding of selectin ligands also leads to the release of chemokines, which can create a permissive microenvironment that supports tumor growth and metastasis.\n\nMoreover, studies have shown that specific selectin ligands, such as sLe^X and sLe^A, progressively increase from normal tissue to early-stage cancer and further to metastatic disease. This suggests that circulating tumor cells (CTCs) retain and upregulate selectin ligands generated at the primary tumor site, enhancing their metastatic potential.\n\nIn summary, increased selectin ligand expression on tumor cells enhances their adhesion to the endothelium, activates integrins, promotes chemokine release, and contributes to the formation of a supportive microenvironment for metastasis. This multifaceted role underscores the importance of selectin ligands as potential therapeutic targets in cancer treatment.
subject: Medicine
file_name: how-does-increased-selectin-ligand-expression-contribute-to-cancer-metastasis.md
url: /learn/medicine/questions/how-does-increased-selectin-ligand-expression-contribute-to-cancer-metastasis
score: -1.0
related_article1:
    id: 88677
    title: >-
        How does core fucosylation contribute to cancer development?
    subject: Health Studies
    url: /learn/health-studies/questions/how-does-core-fucosylation-contribute-to-cancer-development
related_article2:
    id: 88672
    title: >-
        How does the epithelial-mesenchymal transition (EMT) relate to glycosylation changes in cancer?
    subject: Health Studies
    url: /learn/health-studies/questions/how-does-the-epithelialmesenchymal-transition-emt-relate-to-glycosylation-changes-in-cancer
---

&nbsp;